Towards quality assurance in the determination of lysosomal enzymes: A two‐centre study
- 1 September 2003
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 26 (6) , 571-581
- https://doi.org/10.1023/a:1025904132569
Abstract
The definitive diagnosis of lysosomal storage disorders depends on the determination of enzymatic activities in cells, tissues or body fluids. At present, neither an evaluation of the different methods nor an interlaboratory quality assurance scheme is available. We have therefore determined the activities of total hexosaminidase, hexosaminidase A and β‐galactosidase in the same samples (n=15) at two metabolic centres in Germany. Three different enzymatic methods were employed, two of which were based on leukocytes as enzyme source and one on dried blood spots. The results obtained by the two different methods using leukocytes proved comparable. In contrast, assays with dried blood spots showed poor correlation with results from leukocytes, possibly because enzymatic activity in dried blood is mainly derived from soluble plasma proteins. Nevertheless, accurate detection of a true enzyme deficiency was also possible in dried blood spots. All enzymes were highly stable when mailed frozen (recovery 98–120%). Enzymatic activities in dried blood samples were also stable at room temperature and were not affected even by exposure to elevated temperatures (50°C for 3h). Dried blood seems to be especially well suited for mailing from distant healthcare facilities, although more accurate results can be expected from leukocytes. In summary, comparability and pitfalls within a lysosomal quality assurance programme were evaluated.Keywords
This publication has 12 references indexed in Scilit:
- Rapid and Simple Assay for the Determination of Tripeptidyl Peptidase and Palmitoyl Protein Thioesterase Activities in Dried Blood SpotsClinical Chemistry, 2003
- Hurler-like phenotype: enzymatic diagnosis in dried blood spots on filter paper.2001
- Tay-Sachs Disease Carrier Screening: A 21-Year ExperienceGenetic Testing, 2000
- Biochemical consequences of mutations causing the GM2 gangliosidosesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999
- A new simple enzyme assay for pre- and postnatal diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) and its variantsJournal of Medical Genetics, 1999
- Glycosphingolipid degradation and animal models of GM2‐gangliosidosesJournal of Inherited Metabolic Disease, 1998
- Synthesis of and its use in classification of GM2 gangliosidosis genotypesClinica Chimica Acta; International Journal of Clinical Chemistry, 1984
- Usefulness of 4‐methylumbelliferyl‐6‐ sulfo‐2‐acetamido‐2‐deoxy‐β‐D‐glucopyranoside for the diagnosis of GM2 gangliosidoses in leukocytesClinical Genetics, 1984
- Clinical Course of GM1GangliosidosesNeuropediatrics, 1984
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951